| Title | The effect of tixagevimab-cilgavimab on clinical outcomes in patients with COVID-19: A systematic review with meta-analysis |
| Author | |
| Corresponding Author | Hou, Mengzhuo |
| Publication Years | 2023
|
| DOI | |
| Source Title | |
| ISSN | 0163-4453
|
| EISSN | 1532-2742
|
| Volume | 86Issue:1 |
| URL | [Source Record] |
| Indexed By | |
| Language | English
|
| SUSTech Authorship | Corresponding
|
| WOS Research Area | Infectious Diseases
|
| WOS Subject | Infectious Diseases
|
| WOS Accession No | WOS:000912492500001
|
| Publisher | |
| ESI Research Field | IMMUNOLOGY
|
| Data Source | Web of Science
|
| Citation statistics |
Cited Times [WOS]:1
|
| Document Type | Journal Article |
| Identifier | http://kc.sustech.edu.cn/handle/2SGJ60CL/425219 |
| Department | Department of Biomedical Engineering |
| Affiliation | 1.Wuhan Univ, Zhongnan Hosp, Dept Neurosurg, Wuhan 430071, Peoples R China 2.Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1, D-55131 Mainz, Germany 3.Wuhan Univ, Zhongnan Hosp, Neurorehabil Dept, Wuhan, Peoples R China 4.Southern Univ Sci & Technol, Dept Biomed Engn, Shenzhen, Peoples R China |
| Corresponding Author Affilication | Department of Biomedical Engineering |
| Recommended Citation GB/T 7714 |
Wang, Yong,Zheng, Jun,Zhu, Kongfu,et al. The effect of tixagevimab-cilgavimab on clinical outcomes in patients with COVID-19: A systematic review with meta-analysis[J]. JOURNAL OF INFECTION,2023,86(1).
|
| APA |
Wang, Yong,Zheng, Jun,Zhu, Kongfu,Xu, Chengshi,Wang, Daping,&Hou, Mengzhuo.(2023).The effect of tixagevimab-cilgavimab on clinical outcomes in patients with COVID-19: A systematic review with meta-analysis.JOURNAL OF INFECTION,86(1).
|
| MLA |
Wang, Yong,et al."The effect of tixagevimab-cilgavimab on clinical outcomes in patients with COVID-19: A systematic review with meta-analysis".JOURNAL OF INFECTION 86.1(2023).
|
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment